Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer

October 11, 2010 By Bio-Medicine.Org

PLEASANTON, Calif., Oct. 11 /PRNewswire/ — Roche Molecular
Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the German Cancer
Research Center (DKFZ) announced today that they have entered into
a research collaboration to enable more specific prediction of a
woman’s risk for developing cervical cancer.

The collaboration is based on recent DKFZ research indicating
that the relative amounts of specific spliced viral RNA molecules
(i.e., RNA markers) in HPV-infected cells enable highly accurate
discrimination of cervical cancer and high-grade (pre-cancer) from
low-grade cervical lesions.

RMD and DKFZ initiated the three-year collaboration in September
2010. DKFZ is conducting research on Roche proprietary platforms,
facilitating direct transition and application of any relevant
findings to the Roche diagnostics product line.

“DKFZ is among the world’s leading HPV research institutes.
Through this collaboration, we have the opportunity to work with
them to further improve screening and diagnosis of cervical
cancer,” said Paul Brown, Ph.D., president and CEO of Roche
Molecular Diagnostics. “Our hope is that this will ultimately lead
to the development of a new test to make cervical cancer screening,
diagnosis and grading even more accurate and specific.”

“From our previous laboratory results on HPV RNA patterns we
believe that our test system will specifically and reliably detect
women at high risk for cervical cancer. With Roche we have the
great opportunity to work with a strong and experienced development
partner for translating our laboratory results into a valid
diagnostic product from which women will benefit,” said Professor
Lutz Gissmann.

“The ATHENA U.S. registration trial demonstrated clearly the
sensitivity and diagnostic value that HPV DNA testing provides as
compared to cytologic examination with a Pap test,” said Brown. “As
a company, Roche is committed to continuing this type of
groundbreaking HPV research to improve di

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech